IDEAS home Printed from https://ideas.repec.org/r/aph/ajpbhl/10.2105-ajph.2007.131714_4.html
   My bibliography  Save this item

The promotion and marketing of oxycontin: Commercial triumph, public health tragedy

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Janet Currie & Hannes Schwandt, 2021. "The Opioid Epidemic Was Not Caused by Economic Distress but by Factors That Could Be More Rapidly Addressed," The ANNALS of the American Academy of Political and Social Science, , vol. 695(1), pages 276-291, May.
  2. Strulik, Holger, 2021. "From pain patient to junkie: An economic theory of painkiller consumption and its impact on wellbeing and longevity," Journal of Health Economics, Elsevier, vol. 76(C).
  3. Louis‐Philippe Beland & Jason Huh & Dongwoo Kim, 2024. "The effect of opioid use on traffic fatalities," Health Economics, John Wiley & Sons, Ltd., vol. 33(6), pages 1123-1132, June.
  4. Bardwell, Geoff & Small, Will & Lavalley, Jennifer & McNeil, Ryan & Kerr, Thomas, 2021. "“People need them or else they're going to take fentanyl and die”: A qualitative study examining the ‘problem’ of prescription opioid diversion during an overdose epidemic," Social Science & Medicine, Elsevier, vol. 279(C).
  5. Strulik, Holger, 2020. "Opioid epidemics," Economics & Human Biology, Elsevier, vol. 37(C).
  6. Gerald F. Davis, 2021. "Corporate Purpose Needs Democracy," Journal of Management Studies, Wiley Blackwell, vol. 58(3), pages 902-913, May.
  7. Glei, Dana A. & Stokes, Andrew & Weinstein, Maxine, 2020. "Changes in mental health, pain, and drug misuse since the mid-1990s: Is there a link?," Social Science & Medicine, Elsevier, vol. 246(C).
  8. Anne Case & Angus Deaton, 2017. "Mortality and Morbidity in the 21st Century," Working Papers 2017-spring, Princeton University, Woodrow Wilson School of Public and International Affairs, Research Program in Development Studies..
  9. Yang, Tse-Chuan & Shoff, Carla & Kim, Seulki, 2022. "Social isolation, residential stability, and opioid use disorder among older Medicare beneficiaries: Metropolitan and non-metropolitan county comparison," Social Science & Medicine, Elsevier, vol. 292(C).
  10. Anne Case & Angus Deaton, 2017. "Mortality and Morbidity in the 21st Century," Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution, vol. 48(1 (Spring), pages 397-476.
  11. Graham, Francis W. & de New, Sonja C. & Nielsen, Suzanne & Petrie, Dennis, 2023. "Revisiting the OxyContin Reformulation: The Role of Licit Substitutes," IZA Discussion Papers 16653, Institute of Labor Economics (IZA).
  12. Sim, Yongbo, 2023. "The effect of opioids on crime: Evidence from the introduction of OxyContin," International Review of Law and Economics, Elsevier, vol. 74(C).
  13. Ravi Katari, Dean Baker, 2015. "Patent Monopolies and the Costs of Mismarketing Drugs," CEPR Reports and Issue Briefs 2015-11, Center for Economic and Policy Research (CEPR).
  14. Deiana, Claudio & Giua, Ludovica & Nistico, Roberto, 2019. "The Economics behind the Epidemic: Afghan Opium Price and Prescription Opioids in the US," IZA Discussion Papers 12872, Institute of Labor Economics (IZA).
  15. Sheryl Spithoff & Pamela Leece & Frank Sullivan & Nav Persaud & Peter Belesiotis & Liane Steiner, 2020. "Drivers of the opioid crisis: An appraisal of financial conflicts of interest in clinical practice guideline panels at the peak of opioid prescribing," PLOS ONE, Public Library of Science, vol. 15(1), pages 1-15, January.
  16. David Cho & Daniel I. García & Joshua Montes & Alison E. Weingarden, 2021. "Labor Market Effects of the Oxycodone-Heroin Epidemic," Finance and Economics Discussion Series 2021-025, Board of Governors of the Federal Reserve System (U.S.).
  17. Janet Currie & Hannes Schwandt, 2020. "The Opioid Epidemic Was Not Primarily Caused by Economic Distress But by Other Factors that Can be More Readily Addressed," Working Papers 2020-25, Princeton University. Economics Department..
  18. David M. Cutler & Edward L. Glaeser, 2021. "When Innovation Goes Wrong: Technological Regress and the Opioid Epidemic," Journal of Economic Perspectives, American Economic Association, vol. 35(4), pages 171-196, Fall.
  19. Snapp, Zara & Tinasti, Khalid & Herrera Valderrábano, Jorge, 2019. "Regulation of illegal drugs: state control and fragile institutional capacity," LSE Research Online Documents on Economics 102964, London School of Economics and Political Science, LSE Library.
  20. Sacks, Daniel W. & Hollingsworth, Alex & Nguyen, Thuy & Simon, Kosali, 2021. "Can policy affect initiation of addictive substance use? Evidence from opioid prescribing," Journal of Health Economics, Elsevier, vol. 76(C).
  21. Boslett, Andrew & Hill, Elaine, 2022. "Mortality during resource booms and busts," Journal of Environmental Economics and Management, Elsevier, vol. 115(C).
  22. Shiyu Zhang & Daniel Guth, 2021. "The OxyContin Reformulation Revisited: New Evidence From Improved Definitions of Markets and Substitutes," Papers 2101.01128, arXiv.org, revised Jan 2021.
  23. William N. Evans & Ethan M. J. Lieber & Patrick Power, 2019. "How the Reformulation of OxyContin Ignited the Heroin Epidemic," The Review of Economics and Statistics, MIT Press, vol. 101(1), pages 1-15, March.
  24. Johanna Catherine Maclean & Justine Mallatt & Christopher J. Ruhm & Kosali Simon, 2022. "The Opioid Crisis, Health, Healthcare, and Crime: A Review of Quasi-Experimental Economic Studies," The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 15-49, September.
  25. Carolina Arteaga Cabrales & Victoria Barone, 2021. "The Opioid Epidemic: Causes and Consequences," Working Papers tecipa-698, University of Toronto, Department of Economics.
  26. Park, Sujeong & Powell, David, 2021. "Is the rise in illicit opioids affecting labor supply and disability claiming rates?," Journal of Health Economics, Elsevier, vol. 76(C).
  27. Shannon M. Monnat, 2019. "The Contributions of Socioeconomic and Opioid Supply Factors to Geographic Variation in U.S. Drug Mortality Rates," Working Papers Series 87, Institute for New Economic Thinking.
  28. Thuy D. Nguyen & W. David Bradford & Kosali I. Simon, 2019. "How do Opioid Prescribing Restrictions Affect Pharmaceutical Promotion? Lessons from the Mandatory Access Prescription Drug Monitoring Programs," NBER Working Papers 26356, National Bureau of Economic Research, Inc.
  29. Abhimanyu Sud & Darren K. Cheng & Rahim Moineddin & Erin Zlahtic & Ross Upshur, 2021. "Time series-based bibliometric analysis of a systematic review of multidisciplinary care for opioid dose reduction: exploring the origins of the North American opioid crisis," Scientometrics, Springer;Akadémiai Kiadó, vol. 126(11), pages 8935-8955, November.
  30. James F. Anderson & Kelley Reinsmith-Jones & Willie M. Brooks, Jr. & Adam H. Langsam, 2017. "Paradigm Shift in Responding to Drug Users and Addicts: From a Criminal Justice to a Public Health Approach," International Journal of Social Science Studies, Redfame publishing, vol. 5(5), pages 1-15, May.
  31. Jessica Y. Ho, 2020. "Cycles of Gender Convergence and Divergence in Drug Overdose Mortality," Population and Development Review, The Population Council, Inc., vol. 46(3), pages 443-470, September.
  32. Bastian Rosner & Jessica Neicun & Justin Christopher Yang & Andres Roman-Urrestarazu, 2019. "Opioid prescription patterns in Germany and the global opioid epidemic: Systematic review of available evidence," PLOS ONE, Public Library of Science, vol. 14(8), pages 1-20, August.
  33. William Encinosa & Didem Bernard & Thomas M. Selden, 2022. "Opioid and non-opioid analgesic prescribing before and after the CDC’s 2016 opioid guideline," International Journal of Health Economics and Management, Springer, vol. 22(1), pages 1-52, March.
  34. Daniele, Gianmarco & Le Moglie, Marco & Masera, Federico, 2023. "Pains, guns and moves: The effect of the U.S. opioid epidemic on Mexican migration," Journal of Development Economics, Elsevier, vol. 160(C).
  35. McGranahan, David A. & Parker, Timothy S., 2021. "The Opioid Epidemic: A Geography in Two Phases," USDA Miscellaneous 310390, United States Department of Agriculture.
  36. Francisco A. Montiel Ishino & Tamika Gilreath & Faustine Williams, 2020. "Finding the Hidden Risk Profiles of the United States Opioid Epidemic: Using a Person-Centered Approach on a National Dataset of Noninstitutionalized Adults Reporting Opioid Misuse," IJERPH, MDPI, vol. 17(12), pages 1-14, June.
  37. Mark A. Bellis & Sally McManus & Karen Hughes & Olumide Adisa & Kat Ford, 2024. "The Commercial Determinants of Violence: Identifying Opportunities for Violence Prevention through a Public Health-Based Framework Analysis," IJERPH, MDPI, vol. 21(3), pages 1-18, March.
  38. McGranahan, David & Parker, Timothy, 2021. "The Opioid Epidemic: A Geography in Two Phases," Economic Research Report 327197, United States Department of Agriculture, Economic Research Service.
  39. Alireza Boloori & Bengt B. Arnetz & Frederi Viens & Taps Maiti & Judith E. Arnetz, 2020. "Misalignment of Stakeholder Incentives in the Opioid Crisis," IJERPH, MDPI, vol. 17(20), pages 1-19, October.
  40. Quinn Grundy & Sasha Mazzarello & Sarah Brennenstuhl & Emily A Karanges, 2021. "A comparison of educational events for physicians and nurses in Australia sponsored by opioid manufacturers," PLOS ONE, Public Library of Science, vol. 16(3), pages 1-18, March.
  41. Claudio Deiana & Ludovica Giua & Roberto Nisticò, 2024. "Opium Price Shocks and Prescription Opioids in the USA," Oxford Bulletin of Economics and Statistics, Department of Economics, University of Oxford, vol. 86(3), pages 449-484, June.
  42. van Amsterdam, Jan & Phillips, Lawrence D. & Henderson, Graeme & Bell, James & Bowden-Jones, Owen & Hammersley, Richard & Ramsey, John & Taylor, Polly & Dale-Perera, Annette & Melichar, Jan & van den , 2015. "Ranking the harm of non-medically used prescription opioids in the UK," LSE Research Online Documents on Economics 64653, London School of Economics and Political Science, LSE Library.
  43. Shishir Shakya & Collin Hodges, 2023. "Must‐access prescription drug monitoring programs and retail opioid sales," Contemporary Economic Policy, Western Economic Association International, vol. 41(1), pages 146-165, January.
  44. David M. Cutler & Edward L. Glaeser, 2021. "When Innovation Goes Wrong: Technological Regress and the Opioid Epidemic," NBER Working Papers 28873, National Bureau of Economic Research, Inc.
  45. Roxana Damiescu & Mita Banerjee & David Y. W. Lee & Norbert W. Paul & Thomas Efferth, 2021. "Health(care) in the Crisis: Reflections in Science and Society on Opioid Addiction," IJERPH, MDPI, vol. 18(1), pages 1-17, January.
  46. Jessica Y. Ho, 2019. "The Contemporary American Drug Overdose Epidemic in International Perspective," Population and Development Review, The Population Council, Inc., vol. 45(1), pages 7-40, March.
  47. Shannon M. Monnat, 2022. "Demographic and Geographic Variation in Fatal Drug Overdoses in the United States, 1999–2020," The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 50-78, September.
  48. Alexander Ahammer & Martin Halla, 2022. "The intergenerational persistence of opioid dependence: Evidence from administrative data," Health Economics, John Wiley & Sons, Ltd., vol. 31(11), pages 2425-2444, November.
  49. Janssen, Aljoscha & Zhang, Xuan, 2020. "Retail Pharmacies and Drug Diversion during the Opioid Epidemic," Working Paper Series 1373, Research Institute of Industrial Economics.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.